A beacon for academic excellence and pioneering research – unique to, and integrated with, the Melbourne Biomedical Precinct and its Parkland context.

Background

Monash Institute of Pharmaceutical Sciences (MIPS) is internationally renowned for advancing pharmaceutical education and research excellence. Monash University is undertaking a revitalisation project to transform a six-story building, recently acquired from CSIRO, into a world class innovative research hub; fostering a dynamic, sustainable and connected environment that cultivates pioneer research for diverse user groups. The redevelopment involves conducting a complete refurbishment from the stripped back structure with a combination of fit-for-purpose PC2 research laboratories, office spaces, breakout areas and animal facilities to enhance research.

Johnstaff's role

Johnstaff was engaged during the Design Development phase to provide project management services, including superintendent services, through to project completion. The project focuses on the refurbishment and revitalisation of the existing buildings. Design finalisation was progressed concurrently with the strip out demolition to the building frame. Through, and in parallel with, the finalisation of design, Johnstaff has worked collaboratively with Monash University and the consultant team to undertake complex risk and cost management and mitigation exercises.

Leveraging Johnstaff’s experience and expertise on other similar tertiary and research facilities, Johnstaff has managed design responses to adhere to laboratory protocols and that solutions are within available budgets, all whilst providing advice on programme, sequencing, authorities engagement and procurement to ensure project objectives are achieved.

Addressing the issues

Johnstaff provided bespoke procurement advice, resulting in a procurement model that has greater alignment with Monash University’s preferred risk profile for the project. Concurrent with the finalisation of design, Johnstaff implemented further project controls to reduce risk and maximise cost efficiency to the client.

Outcomes

Managed stakeholder engagement and communication
Changed procurement methodology to mitigated latent conditions and associated risks
Provided detailed assessment of the current state of the project and recommendations to assist in completion of the phases
Facility features PC2 laboratories, offices, shared workspace and animal facilities